HTR1A and Anxiety: Pharmacologically, targeting the 5-HT1A receptor has shown promise in treating various symptoms associated with neurodevelopmental disorders [58], including respiratory deficits, anxiety, and stereotypical movements in ASD and RTT syndrome [158].